Three new #obesity drugshigh dose semaglutide, semaglutide plus cagrilintide, and oral orforglipronmay soon be approved in the US. JAMA Medical News Director Jennifer Abbasi and Lead Senior Staff Writer Rita Rubin examine how Challenging Clinical Perspectives in Type 2 Diabetes with Tirzepatide, a First in Class Twincretin Diabetes Therapy Springer Nature Link Blog PRIME Medicine Switching to Tirzepatide 5 mg From Glucagon Like Peptide 1 Receptor Agonists: Clinical Expectations in the First 12 Weeks of Treatment Endocrine Practice Tirzepatide Injectable Peptide Cagrilintide and tirzepatide are NOT medically equivalent, and one cannot replace the other like a refill. , Tirzepatide is FDA approved and dosed once weekly with careful titration based on